<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-08-30 23:12:56Medicine Pharmaceutical sciences 17-Hydroxyprogesterone caproate 17-Hydroxyprogesterone Telaprevir Ribavirin Boceprevir Massachusetts health care reform Food and Drug Administration Protease inhibitors Antivirals Pharmacology |
Add to Reading List |
Microsoft Word - #Prescriber e-Letter-Volume 4-Issue 4_11Aug.doc | August 13, 2014 Sylvia Mathews Burwell, Secretary U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, D.CDear Secretary Burwell:DocID: 19wW8 - View Document |
| DISCUSSION RESOURCE GUIDE Progesterone Promotion What is 17P? 17 alpha-hydroxyprogesterone caproate (17P) is a synthetic form of progesterone that has been shown to reduce the recurrence of preterm birth (PTB) for womenDocID: 19vZo - View Document |
| [Federal Register: September 13, 2000 (Volume 65, NumberNotices] [PageFrom the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr13se00-81] --------------------------------------DocID: 17M6C - View Document |
| PDF DocumentDocID: 14tuc - View Document |
| Strategies to prevent preterm birthDocID: 10MBe - View Document |